InvestorQ : Why is the WHO approval of COVAXIN of Bharat Biotech getting delayed?
Angel dcosta made post

Why is the WHO approval of COVAXIN of Bharat Biotech getting delayed?

Answer
image
Juvina Maggie answered.
2 months ago
Follow

There is a more pragmatic side to the story. In fact, the WHO reiterated it cannot cut corners on the approval process for Bharat Biotech’s COVAXIN. Bharat Biotech has been submitting data to WHO on a rolling basis and the Emergency Use Listing (EUL) will depend on how quickly Bharat Biotech furnishes the required data.

This data is needed by WHO to evaluate the vaccine’s quality, safety and efficacy. Dr. Soumya Swaminathan of WHO has announced that the technical advisory group of WHO would meet on 26-Oct to discuss EUL for COVAXIN.

3 Views